Pfizer, Tempus collaborate on cancer drug development
Mobi Health News
MARCH 2, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
Drug Development Related Topics 
LabCorp's latest deal hones in on digital clinical trials for drug development
Mobi Health News
MAY 28, 2020
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
Drug Development 
183
183 Drug Development 183
183 Join 82,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
AI drug developer Alto Neuroscience raises $25M and more digital health fundings
Mobi Health News
JANUARY 31, 2023
Cough monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.
Drug Development 254
254 
Sanofi and TrialSpark partner to accelerate tech-driven drug development
Mobi Health News
OCTOBER 4, 2022
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
Drug Development 250
250 Drug Development 250
250 
Optum: Why COVID-19 could significantly change the drug development pipeline
FierceHealthIT
DECEMBER 11, 2020
Optum: Why COVID-19 could significantly change the drug development pipeline. Fri, 12/11/2020 - 12:12.
Drug Development 135
135 Drug Development 135
135 
Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development
FierceHealthIT
JANUARY 20, 2022
Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development. Thu, 01/20/2022 - 17:06.
Drug Development 105
105 Drug Development 105
105 
New Flagship Pioneering drug development company exits stealth mode
Mobi Health News
OCTOBER 1, 2020
Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.
Drug Development 206
206 Drug Development 206
206 
Optum: Why payers should be watching flurry of drug development activity around eczema
FierceHealthIT
MAY 3, 2021
Optum: Why payers should be watching flurry of drug development activity around eczema. Mon, 05/03/2021 - 15:53.
Drug Development 105
105 Drug Development 105
105 
Infographic: Digital Measures in Oncology Drug Development
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
Infographic: Digital Measures in Oncology Drug Development
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
Clover Health launches drug development subsidiary
FierceHealthIT
JULY 11, 2019
Startup Medicare Advantage insurer Clover Health has launched a new drug development subsidiary called Clover Therapeutics.
Heal plans layoffs ahead of potential sale and more digital health briefs
Mobi Health News
DECEMBER 28, 2022
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Digital Health 268
268 
AI-powered pathology startup PathAI teams up with GSK for drug discovery
Mobi Health News
APRIL 5, 2022
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
Drug Development 256
256 Drug Development 256
256 
The next revolution in the pharmaceutical industry: the transformative potential of AI
Digital Health Global
SEPTEMBER 19, 2023
Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.
Fujitsu teams up with Riken to release new drug discovery tech
Mobi Health News
MAY 19, 2022
They aim to bring down the period and costs for new drug development.
Drug Development 279
279 Drug Development 279
279 
From start to finish, drug development could benefit from cloud computing
Mobi Health News
JULY 9, 2019
From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.
Drug Development 192
192 Drug Development 192
192 
How telemedicine is increasing diversity in clinical trials
KevinMD
MARCH 14, 2019
An important part of advancing medical research and drug development is making participation in clinical trials easier and more inclusive. To develop treatments that work on men, women, and children of all ages and different ethnicities we need to have clinical trial data that represents our diverse population.
Telemedicine 410
410 
Clover Health's new subsidiary will rely on members, machine learning to fuel drug development
Mobi Health News
JULY 10, 2019
Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.
Drug Development 191
191 Drug Development 191
191 
Truveta welcomes new health system members and raises $95M; YuLife scores $70M to transform life insurance and more digital health fundings
Mobi Health News
JULY 15, 2021
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Drug Development 215
215 
How Technology Is Improving Success Rates In Drug Clinical Trials
Electronic Health Reporter
APRIL 8, 2022
Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drug developed, pass clinical trials and ultimately approved by […]. The article How Technology Is Improving Success Rates In Drug Clinical Trials appeared first on electronichealthreporter.com.
Drug Development 127
127 Drug Development 127
127 
Why is Oncology Drug Development Research Late to the Digital Biomarkers Game?
ActiGraph
DECEMBER 27, 2021
During the recent Annual ASCO Meeting , thousands of cancer researchers and clinicians from across the globe joined together virtually to present and discuss the latest findings and breakthroughs in cancer research and care.
Ben-Gurion University introduces AI platform for monitoring and predicting ALS progression
Mobi Health News
FEBRUARY 19, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.
Drug Development 199
199 Drug Development 199
199 
Healthcare AI Bias: Reasons and Resolutions
Healthcare IT Today
APRIL 14, 2022
Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drug development and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].
Drug Development 124
124 
Curebase Unlocks Drug Development with Remote Clinical Trials; Raises $15m Led by GGV Capital
Healthcare IT Today
MAY 25, 2021
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.
Patients and Industry: Starting Our New Life Together in 2023
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.
BioTech 141
141 
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
Digital Health Global
MARCH 29, 2023
With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We
Machine Learning in Pharma: Mindbreeze InSpire
Healthcare IT Today
NOVEMBER 24, 2021
The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?
Drug Development 119
119 
A roadmap by the FDA for incorporating digital health technologies in clinical trials
Digital Health Global
MARCH 30, 2023
The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. Drug development process questions the reliability and accuracy of DHT products.
Palantir and Healthcare: What could the future hold?
Lloyd Price
MAY 16, 2023
Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Palantir's products are helping these organizations to improve patient care, accelerate research, and improve drug development. What are a few likely scenarios for Palantir in Healthcare? Have a comment?
Accelerate Clinical Development with Patient-Centric Digital Endpoints
ActiGraph
FEBRUARY 1, 2023
Drug development success rates have been on the decline since 2015. 1 The machinery of clinical development urgently needs some new oil. Compounded by the pandemic, trial success rates fell to a 10-year low in 2021, averaging only a 5% likelihood of successful progression through all phases.
How Happy Cells Manufacture New Medications
Healthcare IT Today
APRIL 11, 2023
Here they are producing more accurate and efficient tools for drug development. The biotherapeutics monitoring equipment from 908 Devices illustrates the positive role technology—sensitive measuring devices, analytics, and automation—can play in medicine.
Accelerate Clinical Development with Patient-Centric Digital Endpoints
ActiGraph
FEBRUARY 1, 2023
Drug development success rates have been on the decline since 2015. 1 The machinery of clinical development urgently needs some new oil. Compounded by the pandemic, trial success rates fell to a 10-year low in 2021, averaging only a 5% likelihood of successful progression through all phases.
QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials
Digital Health Global
AUGUST 30, 2023
QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.
BioTech 52
52 
Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers
Digital Health Global
JUNE 13, 2023
We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. “The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re
eMed 52
52 
BenevolentAI gets $115M to harness AI for new drug discovery
Mobi Health News
APRIL 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States. Existing backer Woodford Investment Management also participated in the round, which brings the company’s total funds raised to over $200 million.
Drug Development 131
131 Drug Development 131
131 
The Impact of Agile In The Pharmaceutical Industry
Electronic Health Reporter
SEPTEMBER 17, 2020
As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. Illegal copying is prohibited. By Dimitar Karaivanov, CEO and co-founder, Kanbanize. Without a direct relationship with […].
Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials
Digital Health Global
MARCH 2, 2023
As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.
Protai Adds $12 Million to Seed Round – Bringing the Total to $20 Million – to Build an Oncology Drug Discovery Pipeline
Healthcare IT Today
MARCH 23, 2023
“We are excited to announce this funding that supports our mission to enhance the drug development pathway from discovery through commercialization,” said Eran Seger, Co-Founder and CEO at Protai. “I We look forward to scaling our organization and its important work towards revolutionizing the drug development landscape.” “Our
Enriching RWE with Novel Data Sets: How Medical Imaging Data Can Accelerate Drug Development
hea!thcare innovation - Clinical IT
MAY 16, 2019
Real-world evidence has the potential to be especially valuable in a number of healthcare use cases
Prognos Health Raises $23 Million
Healthcare IT Today
MAY 22, 2023
.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.
Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders
Digital Health Global
JUNE 20, 2023
Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.
How Technology Can Help Overcome Barriers to Getting Effective Therapies into Patients with Ultra Rare Disorders
Healthcare IT Today
SEPTEMBER 28, 2022
Already, this real-world, distributed time of diagnosis approach, has been used to cut down more than four years of estimated drug development timeline in the instance of PRAX-222, a new therapy for SCN2A, a rare genetic disorder of pediatric epilepsy.
Drug Development 106
106 
Labcorp teams up with Ascension to expand services in several states
Healthcare IT News - Telehealth
FEBRUARY 11, 2022
The companies drew particular attention to Labcorp Drug Development, which Ascension says it can use to present physicians and patients with access to clinical trials, innovative therapies and new treatment options where appropriate. Labcorp also said it would use proprietary analytic tools and processes to improve overall efficiency.
Healthcare IT 169
169 
COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation
Healthcare IT Today
NOVEMBER 1, 2022
The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology. In conjunction, COTA announced it has raised additional capital from existing investors. COTA Adds Emerging Types of Data to Oncology Real-World Data Platform.
Life Science 92
92 
Let's personalize your content